ALBANY, N.Y. & SHANGHAI–(BUSINESS WIRE)–Drug Farm today announced that preliminary immunologic and clinical results from its Phase 1b study of DF-003, a first-in-class oral ALPK1 inhibitor, will be presented in a podium session at IMMUNOLOGY2026, tak…
Category: News
Phentolamine Eye Drops Ease Presbyopia in Second Randomized Trial
The adrenergic antagonist improved near vision in adults with presbyopia, with over 20 hours of improvement from a single administration in the VEGA-3 trial. Medscape Medical News
Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its one-of-a-kind ONE by ONE Recycling program, created in collabo…
Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its one-of-a-kind ONE by ONE Recycling program, created in collabo…
Glaukos Announces the Release of its 2025 Sustainability Report
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced that …
Postmenopausal HRT Tied to Glaucoma Risk in Women
The use of postmenopausal hormone replacement therapy is associated with an increased risk for glaucoma in Finnish women aged 50 years or older, according to a recent nested case-control study. Medscape Medical News
Glaukos Receives Permanent J-code for Epioxa™
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today the U…
Sedation-Free Cataract Surgery Feasible for Select Patients
In a retrospective case series, surgical control and safety are maintained without systemic anesthesia, showing feasibility to expand use. Medscape Medical News
Eye Shingles Tied to Cancer Risk in Those With Immune Issues
Herpes zoster ophthalmicus is associated with an increased risk for subsequent malignancy among individuals with an underlying history of immune dysregulation, according to a recent cohort study. Medscape Medical News
Cosmetic Eyelash Extensions Linked to Dry Eye Symptoms
Eye symptoms affect most recipients of lash lifts and extensions, with an independent association with dry eye in an observational study. Medscape Medical News
Atia Vision Announces Durable 36-Month Results from First-in-Human Study of their Dynamic Shape-Changing OmniVu Intraocular Lens System
CAMPBELL, Calif.–(BUSINESS WIRE)–Atia Vision Announces Durable 36-Month Results from First-in-Human Study of their Dynamic Shape-Changing OmniVu Intraocular Lens System
4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program
NEWTON, Mass.–(BUSINESS WIRE)– #4DPath–4D Path Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Predictive Biomarkers for an Antibody Drug Conjugate Program
ASCRS 2026
Read clinically focused news coverage of key developments from ASCRS 2026 Medscape Ophthalmology
Lineage Announces Formation of Scientific Advisory Board
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious med…
Insurers Fail to Get Specific on Prior Authorization Reforms
An industry trade group says prior authorization requirements have declined by 11% after last year’s pledge, but the numbers are fuzzy. Medscape Medical News
IDEAYA and Servier’s Eye Cancer Drug Meets Trial Goal, Paving Way for FDA Application
IDEAYA Biosciences and French pharma company Servier said on Monday their combination drug for a type of eye cancer met the main goal of a mid-to-late-stage trial, sending… Reuters Health Information
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
JACKSONVILLE, Fla.–(BUSINESS WIRE)–Johnson & Johnson showcases new clinical data for TECNIS PureSee IOL demonstrating excellent contrast sensitivity and extended range of vision
Should Your Patient Be on Statins? Maybe the Eyes Can Tell
A trial of an AI algorithm that uses retina images to evaluate the risk for atherosclerotic cardiovascular disease demonstrates a high level of accuracy. Medscape Medical News
Medscape Physician Compensation Report 2026: Positive Signs
US physicians report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed. Medscape
Systane Steps Up to the Plate as the Official Eye Drop of the Toronto Blue Jays, Raising Awareness of Dry Eye in Canada
TORONTO–(BUSINESS WIRE)–This season, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced that Systane® has partnered with the Toronto Blue Jays as the official eye drop of the team. The partnership aims to help…